Ensysce Biosciences

ENSCNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.993 M

$0.52 -0.78%

Close of 7 Aug 2026

Revenue

$5.07M

#3296 by revenue

Earnings

—

Not reported

Shares outstanding

9,277,819

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#442Traws PharmaTRAW$8.10M
#443Aprea TherapeuticsAPRE$8.05M
#444Ensysce BiosciencesENSC$7.99M
#445Moleculin BiotechMBRX$7.98M
#446CNS PharmaceuticalsCNSP$7.86M

Where these numbers come from

Share counts and financials for Ensysce Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.